Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Variance in Biomarker Usefulness as Indicators for Carotid and Coronary Atherosclerosis
Insights
Different biomarkers indicate coronary artery disease (CAD) and carotid artery disease (CEAD), despite atherosclerosis being systemic. Identifying these specific biomarkers is crucial for targeted prevention and understanding disease mechanisms.
Area of Science:
- Cardiovascular Medicine
- Biomarker Research
- Atherosclerosis Studies
Background:
- Atherosclerosis is a systemic condition affecting multiple vascular beds.
- The distinct roles of biomarkers in coronary artery disease (CAD) versus carotid artery disease (CEAD) require clarification.
Purpose of the Study:
- To investigate the association between various biomarkers and the presence/severity of both coronary and carotid artery disease.
Main Methods:
- 522 stable angina patients underwent simultaneous coronary angiography and carotid duplex ultrasound.
- Biomarkers including lipids, hemoglobin A1c (HbA1c), white blood cell count, fibrinogen, and high-sensitivity C-reactive protein (hs-CRP) were measured.
- Carotid intima-media thickness (CIMT) was assessed in patients without significant plaque.
Main Results:
- Higher hs-CRP levels correlated with significant carotid stenosis (P=0.001).
- Elevated HbA1c (P<0.001) and low high-density lipoprotein (HDL) cholesterol (P<0.001) were associated with severe coronary artery disease.
- No significant association was found between CIMT and any of the evaluated biomarkers.
Conclusions:
- Biomarkers show differential associations with coronary versus carotid artery disease.
- Specific biomarker identification for each vascular territory is essential for effective prevention strategies.
- Understanding these distinct associations may elucidate underlying pathophysiological mechanisms.
Background:
Atherosclerosis is a systemic disease. Nevertheless, the role of specific biomarkers as indicators for both coronary and carotid diseases is debatable.
Objectives:
To evaluate the association of biomarkers with coronary and carotid disease.
Methods:
We studied 522 consecutive patients with stable angina. All underwent coronary angiography and carotid duplex study on the same day. Patients with no apparent carotid plaques were evaluated for carotid intima-media thickness (CIMT) using an automated system that sampled over 100 samples in each carotid artery. Biochemical markers of cardiovascular disease risk were obtained at the time of coronary angiography, including serum lipid levels, hemoglobin A1C (HbA1c), white blood cell count, fibrinogen and high sensitivity C-reactive protein (hs-CRP).
Results:
The mean age of the patients was 66 ± 11; 73% were males. Significant carotid stenosis was associated with higher hs-CRP (9.4 ± 17 vs. 6.3 ± 13 mg/L, P = 0.001), while high HbA1c (6.7 ± 1.6 vs. 5.8 ± 0.8%, P 0.001) and low high density lipoprotein levels (40 ± 9 vs. 47 ± 14 mg/dl, P < 0.001) were linked with advanced coronary artery disease severity. In contrast, CIMT was not related to any of the biomarkers evaluated.
Conclusions:
Although atherosclerosis is considered a systemic disease, different biomarkers are associated with coronary and carotid artery disease. Identifying the specific biomarkers for each disease is important for both prevention and for exposing the underlying pathophysiologic mechanism.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction

